Lyrica Capsule 300mg

Land: Singapur

Sprache: Englisch

Quelle: HSA (Health Sciences Authority)

Kaufe es jetzt

Herunterladen Gebrauchsinformation (PIL)
19-11-2014
Herunterladen Fachinformation (SPC)
27-10-2021

Wirkstoff:

Pregabalin

Verfügbar ab:

PFIZER PFE PRIVATE LIMITED

ATC-Code:

N03AX16

Dosierung:

300.00mg

Darreichungsform:

CAPSULE

Zusammensetzung:

Pregabalin 300.00mg

Verabreichungsweg:

ORAL

Verschreibungstyp:

Prescription Only

Hergestellt von:

Pfizer Manufacturing Deutschland GmbH

Berechtigungsstatus:

ACTIVE

Berechtigungsdatum:

2005-05-12

Gebrauchsinformation

                                 
 
 
Page  1 of 12 
LYRICA
®
 CAPSULES 
(Pregabalin) 
 
1. 
NAME OF THE MEDICINAL PRODUCT 
 
LYRICA
®
 
 
2. 
QUALITATIVE AND QUANTITATIVE COMPOSITION 
 
Each hard capsule contains 25 mg, 50 mg, 75 mg, 100
 
mg, 150 mg, 200
 
mg, or 300 mg of pregabalin. 
_ _
3. PHARMACEUTICAL 
FORM 
 
25 mg: Size 4, white
opaque/white opaque hard gelatin capsule containing
a white to off-white powder 
with PGN 25 printed on the body and Pfizer printed on the
cap. 
 
50 mg: Size 3, white opaque/white opaque hard gelatin capsule
with a black band containing a white to 
off-white powder with PGN 50 printed on the body
and Pfizer printed on the cap. 
 
75 mg: Size 4, white opaque/orange opaque
hard gelatin capsule containing a white to off-white powder 
with PGN 75 printed on the body and Pfizer printed on the
cap. 
 
100 mg:
Size 3, orange opaque/orange opaque hard gelatin capsule containing a white to off-white 
powder with PGN 100 printed on the body and Pfizer printed on
the cap. 
 
150 mg: Size 2 white opaque/white opaque
hard gelatin capsule containing a white to off-white powder 
with PGN 150 printed on the body and Pfizer printed on the
cap. 
 
200 mg: Size 1
light orange opaque/light orange opaque hard gelatin
capsule containing a white to 
off-white powder with PGN 200 printed
on the body and Pfizer printed on the cap. 
 
300 mg:
Size 0 white opaque/orange opaque hard gelatin capsule containing a white to off-white powder 
with PGN 300 printed on the body and Pfizer printed on the
cap. 
 
4. CLINICAL 
PARTICULARS 
 
4.1 THERAPEUTIC 
INDICATIONS 
 
Neuropathic pain 
 
Pregabalin is indicated for the treatment
of neuropathic pain which includes diabetic peripheral 
neuropathy and post-herpetic neuralgia in adults. 
 
Epilepsy 
 
Pregabalin is indicated as adjunctive therapy
of partial seizures,
                                
                                Lesen Sie das vollständige Dokument
                                
                            

Fachinformation

                                LYRICA
® CAPSULES
(Pregabalin)
1.
NAME OF THE MEDICINAL PRODUCT
LYRICA
®
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each hard capsule contains 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200
mg, or 300 mg of pregabalin.
3.
PHARMACEUTICAL FORM
25 mg: Size 4, white opaque/white opaque hard gelatin capsule
containing a white to off-white
powder with PGN 25 printed on the body and Pfizer printed on the cap.
50 mg: Size 3, white opaque/white opaque hard gelatin capsule with a
black band containing a white
to off-white powder with PGN 50 printed on the body and Pfizer printed
on the cap.
75 mg: Size 4, white opaque/orange opaque hard gelatin capsule
containing a white to off-white
powder with PGN 75 printed on the body and Pfizer printed on the cap.
100 mg: Size 3, orange opaque/orange opaque hard gelatin capsule
containing a white to off-white
powder with PGN 100 printed on the body and Pfizer printed on the cap.
150 mg: Size 2 white opaque/white opaque hard gelatin capsule
containing a white to off-white
powder with PGN 150 printed on the body and Pfizer printed on the cap.
200 mg: Size 1 light orange opaque/light orange opaque hard gelatin
capsule containing a white to
off-white powder with PGN 200 printed on the body and Pfizer printed
on the cap.
300 mg: Size 0 white opaque/orange opaque hard gelatin capsule
containing a white to off-white
powder with PGN 300 printed on the body and Pfizer printed on the cap.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Neuropathic pain
Pregabalin is indicated for the treatment of neuropathic pain, which
includes diabetic peripheral
neuropathy and post-herpetic neuralgia, in adults.
Epilepsy
Pregabalin
is
indicated
as
adjunctive
therapy
of
partial
seizures,
with
or
without
secondary
generalisation, in adults.
Generalised anxiety disorder
Pregabalin is indicated for the treatment of Generalised Anxiety
Disorder (GAD) in adults.
Fibromyalgia
Pregabalin is indicated for the management of fibromyalgia.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
The dose range is 150 to 600 mg per da
                                
                                Lesen Sie das vollständige Dokument
                                
                            

Suchen Sie nach Benachrichtigungen zu diesem Produkt